The largest drug
discovery company
in the CEE region


Your integrated drug
discovery partner of choice


Developing breakthrough
therapies in oncology


Delivering comprehensive
research solutions to biotech
and pharma


News See all

Selvita and Sandoz chemists published in Bioorganic & Medicinal…

Krakow, Poland – 08 May 2018 – Selvita and Sandoz researchers have recently jointly published an article: “A short synthesis...

Institute of Hematology and Transfusion Medicine and Selvita publish…

Krakow, Poland - 26 April 2018 - Institute of Hematology and Transfusion Medicine, the leading Polish hematology and blood transfusion...

Selvita participates in BioTrinity 2018

Kraków, Poland – 23 April 2018 – Selvita will participate in the 2018 edition of BioTrinity conference, taking place in...

Selvita publishes research results on SEL24 in Oncotarget

Krakow, Poland – 16 April 2018 - Selvita, a clinical stage drug discovery and development company focused on innovative medicines...

Selvita to present new data from its oncology programs…

Kraków, Poland, 06 April 2018 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines...

About Selvita

Selvita has two primary focus areas:

– to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services and

– as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.


Drug Discovery Services

Selvita is a global integrated drug discovery partner for the pharmaceutical and biotechnology industries.

We offer drug discovery support at every stage of the early discovery phase up to the preclinical research phase.


Research and Development

In its internal research and development efforts, Selvita focuses on different dimensions of oncology.

The company’s most advanced R&D program is SEL24, a dual PIM/FLT3 kinase inhibitor currently in Phase I/II clinical study, in acute myeloid leukemia.


Investor Relations SLV +0,00PLN +1,63%

Share price 2018-05-24 17:04:35

56,00 PLN More


We are a multicultural and a multinational company employing professionals from all over the world.

Find out who we’re courrently looking for and what we can offer our employees.